Page last updated: 2024-10-17

aminocaproic acid and Acute Confusional Senile Dementia

aminocaproic acid has been researched along with Acute Confusional Senile Dementia in 2 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kwon, H1
Jung, IH1
Yi, JH1
Kim, JH1
Park, JH1
Lee, S1
Jung, JW1
Lee, YC1
Ryu, JH1
Kim, DH1
Jang, B1
Jeon, YC1
Choi, JK1
Park, M1
Kim, JI1
Ishigami, A1
Maruyama, N1
Carp, RI1
Kim, YS1
Choi, EK1

Other Studies

2 other studies available for aminocaproic acid and Acute Confusional Senile Dementia

ArticleYear
The Seed of Zizyphus jujuba var. spinosa Attenuates Alzheimer's Disease-Associated Hippocampal Synaptic Deficits through BDNF/TrkB Signaling.
    Biological & pharmaceutical bulletin, 2017, Volume: 40, Issue:12

    Topics: Alzheimer Disease; Aminocaproic Acid; Amyloid beta-Peptides; Animals; Brain-Derived Neurotrophic Fac

2017
Peptidylarginine deiminase modulates the physiological roles of enolase via citrullination: links between altered multifunction of enolase and neurodegenerative diseases.
    The Biochemical journal, 2012, Jul-15, Volume: 445, Issue:2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aminocaproic Acid; Animals; Antibodies, Monoclonal; Biom

2012